drugset / Trial / NCT00002679
Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of high-dose sequential chemotherapy as adjuvant therapy in treating patients with stage II or stage III breast cancer who have four or more positive axillary lymph nodes.
Timeline
- Start
- 1994-02
- Primary completion
- 2002-01
- Completion
- 2002-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Paclitaxel | Small molecule | — | — |
| Background | Tamoxifen | Small molecule | — | — |
| Background | filgrastim | Protein / enzyme biologic | — | — |